Nektar Therapeutics | NKTR - Net Income


Nektar Therapeutics reported $-36.08M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agios Pharmaceuticals USD -108.04M 4.61M Dec/2025
ALKERMES USD 49.34M 33.42M Dec/2025
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
BioCryst Pharmaceuticals USD 245.84M 232.95M Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Cara Therapeutics USD -5.53M 621K Sep/2025
Cipla INR 6.76B 6.75B Dec/2025
Dr.Reddys Laboratories INR 12.1B 2.27B Dec/2025
Eisai JPY 17.18B 7.02B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Esperion Therapeutics USD 61.83M 93.16M Dec/2025
Exelixis USD 193.58M 8.73M Sep/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Grifols EUR 114.37M 34.03M Dec/2025
Halozyme Therapeutics USD -141.59M 316.82M Dec/2025
Incyte USD 299.28M 124.89M Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
Karyopharm Therapeutics USD -102.2M 71.42M Dec/2025
MacroGenics USD -14.16M 30.98M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Nektar Therapeutics USD -36.08M 978K Dec/2025
Neurocrine Biosciences USD 209.5M 102M Sep/2025
Novartis USD 2.41B 1.52B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sarepta Therapeutics USD -412.23M 232.28M Dec/2025
Takeda JPY 103.64B 115.44B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
Xencor USD -6.65M 626K Dec/2025